|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 1.670 USD | -2.34% |
|
-28.63% | -76.55% |
| 08-26 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 08-24 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
EPS & Dividend: Scinai Immunotherapeutics Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -402 | -2,833 | -400 | -166.4 | -35.58 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 2,810.000 | 2,350.000 | 296.000 | 59.540 | 7.121 |
| Nbr of stocks (in thousands) | 11.5 | 18.5 | 34.9 | 43.5 | 347 |
| Announcement Date | 5/13/21 | 3/28/22 | 4/17/23 | 5/15/24 | 4/1/26 |
1USD in Million2USD
Estimates
Past dividends: Scinai Immunotherapeutics Ltd.
| 2026-08-21 | Significant Split/Dividend | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.03% | 1.19% | 31.44x | 4.2x | 5.66x | |
| -.--% | -.--% | -21.25x | 21.95x | 245.77x | |
| -.--% | -.--% | 33.09x | 6.04x | 3.22x | |
| -.--% | -.--% | 45.98x | 7.78x | 5.31x | |
| 0.41% | 0.45% | 27.78x | 2.25x | 8.36x | |
| - | - | - | - | 10.19x | |
| -.--% | -.--% | 33.34x | 23.92x | 5.46x | |
| 1.13% | 1.28% | 23.65x | 2.63x | 2.07x | |
| -.--% | -.--% | 74.46x | 4.41x | 3.94x | |
| Average | 0.32% | 0.37% | 31.06x | 9.15x | 32.22x | |
| Weighted average by Cap. | 0.31% | 0.35% | 26.14x | 9.20x | 45.59x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
